TrialJournal of psychopharmacology (Oxford, England)2026

Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trial.

Niall M McGowan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.